Cargando…
Peptidic Inhibitors and a Fluorescent Probe for the Selective Inhibition and Labelling of Factor XIIIa Transglutaminase
Factor XIIIa (FXIIIa) is a transglutaminase of major therapeutic interest for the development of anticoagulants due to its essential role in the blood coagulation cascade. While numerous FXIIIa inhibitors have been reported, they failed to reach clinical evaluation due to their lack of metabolic sta...
Autores principales: | Gates, Eric W. J., Mansour, Kian, Ebrahimi Samani, Sahar, Shad, Sammir, Kaartinen, Mari T., Keillor, Jeffrey W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9960274/ https://www.ncbi.nlm.nih.gov/pubmed/36838622 http://dx.doi.org/10.3390/molecules28041634 |
Ejemplares similares
-
Plasma Membrane Factor XIIIA Transglutaminase Activity Regulates
Osteoblast Matrix Secretion and Deposition by Affecting Microtubule
Dynamics
por: Al-Jallad, Hadil F., et al.
Publicado: (2011) -
Increased Osteoclastogenesis in Absence of TG2 Is Reversed by Transglutaminase Inhibition—Evidence for the Role for TG1 in Osteoclast Formation
por: Ebrahimi Samani, Sahar, et al.
Publicado: (2023) -
Transglutaminases in Monocytes and Macrophages
por: Sun, Huifang, et al.
Publicado: (2018) -
Design of a glutamine substrate tag enabling protein labelling mediated by Bacillus subtilis transglutaminase
por: Oteng-Pabi, Samuel K., et al.
Publicado: (2018) -
Cell-Impermeable Inhibitors Confirm That Intracellular Human Transglutaminase 2 Is Responsible for the Transglutaminase-Associated Cancer Phenotype
por: Gates, Eric W. J., et al.
Publicado: (2023)